Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of dehydroevodiamine in preparation of medicine for treating acute gastritis

A technology for dehydroevodiamine and acute gastritis, which is applied to the application field of dehydroevodiamine in the preparation of medicines for treating acute gastritis, can solve problems such as the absence of dehydroevodiamine on acute gastritis and the like, and achieves improvement of SOD level and ulcers. Formation of significant reduction and improvement effects

Inactive Publication Date: 2021-05-11
THE FIFTH MEDICAL CENT OF CHINESE PLA GENERAL HOSPITAL
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there are no records and reports about the protective effect of dehydroevodiamine on acute gastritis in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of dehydroevodiamine in preparation of medicine for treating acute gastritis
  • Application of dehydroevodiamine in preparation of medicine for treating acute gastritis
  • Application of dehydroevodiamine in preparation of medicine for treating acute gastritis

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0019] Experimental example 1 : Evaluate the therapeutic effect of the target compound (dehydroevodiamine) on acute gastritis by using the acute gastritis model induced by absolute ethanol in mice:

[0020] 1. Method: After adapting to the environment for 1 week, the mice were randomly divided into 4 experimental groups (control group, model group, evodiamine dosage group and dehydroevodiamine dosage group), each group containing 10 animals, Intragastric administration once a day for three consecutive days. The mice in the control group received 1% CMC (sodium carboxymethyl cellulose); the mice in the model group received 1% CMC; the evodiamine dose group was given 20 mg / kg of evodiamine by intragastric administration, and the dehydroevodiamine dose group was given dehydroevodiamine by intragastric administration. Evodiamine 20mg / kg. Before the experiment, the mice were fasted for 12 hours but had free access to water. Then the mice were treated as above, 0.01ml / g dose of ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The application of dehydroevodiamine in the preparation of medicines for treating acute gastritis of the present invention relates to the field of biomedicine. Application of dehydroevodiamine in preparation of medicine for treating acute gastritis. Among them, dehydroevodiamine can significantly improve the levels of MDA and SOD in the gastric mucosa of mice with acute gastritis. Among them, dehydroevodiamine can significantly reduce the gastric mucosal ulcer index in mice. The medicine for treating acute gastritis comprises effective dose of dehydroevodiamine and a pharmaceutically acceptable carrier. The pharmaceutically acceptable carrier is diluent, disintegrant, binder, lubricant or stabilizer. The invention has the following advantages: 1. Dehydroevodiamine can significantly improve the levels of MDA and SOD in the gastric mucosa of mice with acute gastritis; 2. The dehydroevodiamine can significantly reduce the gastric mucosal ulcer index in mice.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to the application of dehydroevodiamine in the preparation of medicines for treating acute gastritis. Background technique [0002] Acute gastritis is a transient disease mainly manifested by extensive or localized hyperemia, edema, hemorrhage, and erosion of the gastric mucosa caused by drugs, stress, ischemia, infection, and bile reflux. Simple gastritis, acute erosive gastritis, acute corrosive gastritis, acute suppurative gastritis, common and frequently-occurring diseases in digestive system diseases, mild patients with nausea, acid regurgitation, stomach burning sensation, abdominal fullness, abdominal pain , mainly diarrhea; severe patients may experience symptoms such as hematemesis, melena, and even poisoning, dehydration, and shock. At present, the main clinical treatment is symptomatic treatment. Relief of pain is the main purpose of clinical treatment of acute gastritis. Comm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/519A61K36/754A61P1/04
CPCA61K31/519A61K36/754A61P1/04
Inventor 赵艳玲魏士长李浩田任思陈韦颖
Owner THE FIFTH MEDICAL CENT OF CHINESE PLA GENERAL HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com